drugset / Trial / NCT07700238
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
RandomizedParallel-groupOpen-labelTreatment
Summary
This Phase 3 study is designed to evaluate the efficacy and safety of romiplostim in combination with predniso(lo)ne compared with predniso(lo)ne alone in adults with previously untreated Primary Immune Thrombocytopenia (ITP).
Timeline
- Start
- 2026-07-20
- Primary completion
- 2029-09-14
- Completion
- 2029-09-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisolone | Other / unclassified | — | Oral |
| Subject | Romiplostim | Peptide | — | Subcutaneous |